Our RESETTM clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris are now recruiting.
Scientific Collaborators
Clinical Collaborators
Industry Partners
Advocacy Partners
Our Cast of Collaborators
Academic and corporate partnerships help accelerate our product development, advance our preclinical studies and clinical trial, and expand the reach of our platform. Collaborations with patient advocacy groups enable us to connect with the patient communities and ensure their voices are heard through our product development journey.